Thermo Fisher Scientific Inc. has announced the grand opening of its Advanced Therapies Collaboration Centre (ATxCC) in Carlsbad, California, US. This advanced facility is designed to accelerate the development and commercialisation of cell therapies, specifically by supporting biotech, biopharma and translational customers developing cell-based immunotherapies.
Through this new centre, cell therapy developers can leverage Thermo Fisher’s expansive product and technology portfolio and deep process optimisation knowledge to create comprehensive, end-to-end manufacturing workflows that can scale to enable clinical and commercial success. This initiative is part of Thermo Fisher’s commitment to advancing life sciences and improving patient outcomes through innovative solutions.
Partnering closely with Thermo Fisher, cell therapy developers can receive the essential resources and support they need to transition to Current Good Manufacturing Practices (cGMP manufacturing). This collaboration helps navigate go-to-market obstacles.
With collaboration centres already established in Singapore and Korea, Thermo Fisher has announced the opening of its Carlsbad centre, with an expanded footprint in Philadelphia expected later this year. Both centres are designed to offer clinical and commercial cGMP process development to its valued partners.
